Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis

The application of allogeneic hematopoietic cell transplantation (allo-HCT) in non-Hodgkin lymphoma (NHL) patients ≥65 years in the United States is limited by lack of Medicare coverage for this indication. Using the Center for International Blood and Marrow Transplant Research (CIBMTR) database, we...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Shah, Nirav N., Ahn, Kwang Woo, Litovich, Carlos, Fenske, Timothy S., Ahmed, Sairah, Battiwalla, Minoo, Bejanyan, Nelli, Dahi, Parastoo B., Bolaños-Meade, Javier, Chen, Andy I., Ciurea, Stefan O., Bachanova, Veronika, DeFilipp, Zachariah, Epperla, Narendranath, Farhadfar, Nosha, Herrera, Alex F., Haverkos, Bradley M., Holmberg, Leona, Hossain, Nasheed M., Kharfan-Dabaja, Mohamed A., Kenkre, Vaishalee P., Lazarus, Hillard M., Murthy, Hemant S., Nishihori, Taiga, Rezvani, Andrew R., D’Souza, Anita, Savani, Bipin N., Ulrickson, Matthew L., Waller, Edmund K., Sureda, Anna, Smith, Sonali M., Hamadani, Mehdi
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2018
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5916010/
https://ncbi.nlm.nih.gov/pubmed/29685953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018018531
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados